Literature DB >> 10958639

Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis.

I L Medintz1, C C Lee, W W Wong, K Pirkola, D Sidransky, R A Mathies.   

Abstract

Microsatellite DNA loci are useful markers for the detection of loss of heterozygosity (LOH) and microsatellite instability (MI) associated with primary cancers. To carry out large-scale studies of LOH and MI in cancer progression, high-throughput instrumentation and assays with high accuracy and sensitivity need to be validated. DNA was extracted from 26 renal tumor and paired lymphocyte samples and amplified with two-color energy-transfer (ET) fluorescent primers specific for loci associated with cancer-induced chromosomal changes. PCR amplicons were separated on the MegaBACE-1000 96 capillary array electrophoresis (CAE) instrument and analyzed with MegaBACE Genetic Profiler v.1.0 software. Ninety-six separations were achieved in parallel in 75 minutes. Loss of heterozygosity was easily detected in tumor samples as was the gain/loss of microsatellite core repeats. Allelic ratios were determined with a precision of +/- 10% or better. Prior analysis of these samples with slab gel electrophoresis and radioisotope labeling had not detected these changes with as much sensitivity or precision. This study establishes the validity of this assay and the MegaBACE instrument for large-scale, high-throughput studies of the molecular genetic changes associated with cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958639      PMCID: PMC310921          DOI: 10.1101/gr.10.8.1211

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  15 in total

1.  Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR.

Authors:  T G Paulson; P C Galipeau; B J Reid
Journal:  Genome Res       Date:  1999-05       Impact factor: 9.043

Review 2.  Loss of constitutional heterozygosity in human cancer.

Authors:  D Lasko; W Cavenee; M Nordenskjöld
Journal:  Annu Rev Genet       Date:  1991       Impact factor: 16.830

3.  High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR.

Authors:  K H Hecker; K H Roux
Journal:  Biotechniques       Date:  1996-03       Impact factor: 1.993

4.  DNA sequencing by capillary electrophoresis with a hydroxyethylcellulose sieving buffer.

Authors:  J Bashkin; M Marsh; D Barker; R Johnston
Journal:  Appl Theor Electrophor       Date:  1996

5.  Detection of bladder cancer recurrence by microsatellite analysis of urine.

Authors:  G Steiner; M P Schoenberg; J F Linn; L Mao; D Sidransky
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

6.  Diagnosis of renal cancer by molecular urinalysis.

Authors:  C F Eisenberger; M Schoenberg; C Enger; S Hortopan; S Shah; N H Chow; F F Marshall; D Sidransky
Journal:  J Natl Cancer Inst       Date:  1999-12-01       Impact factor: 13.506

7.  Energy transfer primers with 5- or 6-carboxyrhodamine-6G as acceptor chromophores.

Authors:  S C Hung; J Ju; R A Mathies; A N Glazer
Journal:  Anal Biochem       Date:  1996-07-01       Impact factor: 3.365

Review 8.  Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites.

Authors:  G Steiner; D Sidransky
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

9.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy.

Authors:  Y H Fu; A Pizzuti; R G Fenwick; J King; S Rajnarayan; P W Dunne; J Dubel; G A Nasser; T Ashizawa; P de Jong
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

10.  Molecular detection of primary bladder cancer by microsatellite analysis.

Authors:  L Mao; M P Schoenberg; M Scicchitano; Y S Erozan; A Merlo; D Schwab; D Sidransky
Journal:  Science       Date:  1996-02-02       Impact factor: 47.728

View more
  8 in total

Review 1.  DNA probes using fluorescence resonance energy transfer (FRET): designs and applications.

Authors:  V V Didenko
Journal:  Biotechniques       Date:  2001-11       Impact factor: 1.993

Review 2.  The use of capillary electrophoresis for DNA polymorphism analysis.

Authors:  Keith R Mitchelson
Journal:  Mol Biotechnol       Date:  2003-05       Impact factor: 2.695

3.  High-performance multiplex SNP analysis of three hemochromatosis-related mutations with capillary array electrophoresis microplates.

Authors:  I Medintz; W W Wong; L Berti; L Shiow; J Tom; J Scherer; G Sensabaugh; R A Mathies
Journal:  Genome Res       Date:  2001-03       Impact factor: 9.043

4.  Assessment of the frequency of allelic imbalance in human tissue using a multiplex polymerase chain reaction system.

Authors:  Christopher M Heaphy; William C Hines; Kimberly S Butler; Christina M Haaland; Glenroy Heywood; Edgar G Fischer; Marco Bisoffi; Jeffrey K Griffith
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

5.  Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Brad Love; Darrell L Ellsworth; Craig D Shriver
Journal:  Pathol Oncol Res       Date:  2009-02-05       Impact factor: 3.201

6.  Molecular alterations associated with breast cancer mortality.

Authors:  Laura M Voeghtly; Kim Mamula; J Leigh Campbell; Craig D Shriver; Rachel E Ellsworth
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

7.  Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.

Authors:  Rachel E Ellsworth; Allyson L Toro; Heather L Blackburn; Alisha Decewicz; Brenda Deyarmin; Kimberly A Mamula; Nicholas S Costantino; Jeffrey A Hooke; Craig D Shriver; Darrell L Ellsworth
Journal:  Cancer Growth Metastasis       Date:  2015-07-20

8.  Amplification of HER2 is a marker for global genomic instability.

Authors:  Rachel E Ellsworth; Darrell L Ellsworth; Heather L Patney; Brenda Deyarmin; Brad Love; Jeffrey A Hooke; Craig D Shriver
Journal:  BMC Cancer       Date:  2008-10-14       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.